Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$1.07B |
 |
MedtronicMDT |
-$67M |
 |
Edwards LifesciencesEW |
-$787M |
 |
Intuitive SurgicalISRG |
-$1.06B |
 |
ConmedCNMD |
-$27M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Ghoshal Kaushik | Oct 11, 2024 | Sell | 4,260 | $238.48 | $1M |
| Sandercock Brett | Oct 8, 2024 | Sell | 1,000 | $233.47 | $230,000 |
| Farrell Michael J. | Oct 7, 2024 | Sell | 14,683 | $231.9149 | $3.4M |
| FARRELL PETER C | Oct 2, 2024 | Sell | 2,000 | $237.2 | $470,000 |
| Ghoshal Kaushik | Sep 12, 2024 | Sell | 5,000 | $252.56 | $1.3M |
| Farrell Michael J. | Sep 9, 2024 | Sell | 14,683 | $248.3791 | $3.6M |
| Sandercock Brett | Sep 9, 2024 | Sell | 1,000 | $246.42 | $250,000 |
| FARRELL PETER C | Sep 4, 2024 | Sell | 2,000 | $239.9 | $480,000 |
| Rider Michael J | Aug 20, 2024 | Sell | 882 | $231 | $200,000 |
| Ghoshal Kaushik | Aug 12, 2024 | Sell | 10,000 | $216.6 | $2.2M |
| Sandercock Brett | Aug 8, 2024 | Sell | 1,000 | $212.16 | $210,000 |
| Farrell Michael J. | Aug 7, 2024 | Sell | 14,683 | $214.2549 | $3.1M |
| Leong Justin | Aug 5, 2024 | Sell | 48,000 | $217.074 | $10M |
| Farrell Michael J. | Jul 8, 2024 | Sell | 14,683 | $192.9667 | $2.8M |
| Sandercock Brett | Jul 8, 2024 | Sell | 1,000 | $194.35 | $190,000 |
| Sandercock Brett | Jun 10, 2024 | Sell | 1,000 | $209.81 | $210,000 |
| Farrell Michael J. | Jun 7, 2024 | Sell | 14,683 | $211.6556 | $3.1M |
| De Witte Jan | May 15, 2024 | Sell | 360 | $218.29 | $79,000 |
| De Witte Jan | May 15, 2024 | Sell | 360 | $218.29 | $79,000 |
| Sandercock Brett | May 8, 2024 | Sell | 13,000 | $211.37 | $2.7M |
| Farrell Michael J. | May 7, 2024 | Sell | 14,683 | $216.4963 | $3.2M |
| Drexler Karen | Apr 29, 2024 | Sell | 425 | $214.92 | $91,000 |
| Rider Michael J | Mar 4, 2024 | Sell | 81 | $180 | $15,000 |
| Rider Michael J | Mar 1, 2024 | Sell | 200 | $173.25 | $35,000 |
| FARRELL PETER C | Feb 22, 2024 | Sell | 10,935 | $182.6643 | $2M |
| Sandercock Brett | Nov 27, 2023 | Sell | 3,000 | $152.6201 | $460,000 |
| Farrell Michael J. | Nov 15, 2023 | Sell | 5,678 | $152.0396 | $860,000 |
| Rider Michael J | Nov 1, 2023 | Sell | 25 | $143.42 | $3,600 |
| Farrell Michael J. | Oct 16, 2023 | Sell | 5,675 | $140.6985 | $800,000 |
| Rider Michael J | Oct 2, 2023 | Sell | 25 | $145.92 | $3,600 |
| Farrell Michael J. | Sep 15, 2023 | Sell | 5,675 | $146.346 | $830,000 |
| Rider Michael J | Sep 1, 2023 | Sell | 25 | $161.15 | $4,000 |
| Farrell Michael J. | Aug 15, 2023 | Sell | 5,675 | $183.1977 | $1M |
| Douglas Robert Andrew | Aug 15, 2023 | Sell | 1,500 | $181.01 | $270,000 |
| Rider Michael J | Aug 1, 2023 | Sell | 25 | $224.12 | $5,600 |
| Farrell Michael J. | Jul 17, 2023 | Sell | 5,675 | $221.2663 | $1.3M |
| Douglas Robert Andrew | Jul 17, 2023 | Sell | 1,500 | $222.22 | $330,000 |
| Ghoshal Kaushik | Jul 13, 2023 | Sell | 500 | $220 | $110,000 |
| Rider Michael J | Jul 3, 2023 | Sell | 25 | $217.21 | $5,400 |
| Douglas Robert Andrew | Jun 15, 2023 | Sell | 1,500 | $216.27 | $320,000 |
| Farrell Michael J. | Jun 15, 2023 | Sell | 5,675 | $217.3949 | $1.2M |
| PENDARVIS DAVID | Jun 5, 2023 | Sell | 1,500 | $219.79 | $330,000 |
| Ghoshal Kaushik | Jun 2, 2023 | Sell | 500 | $220 | $110,000 |
| Farrell Michael J. | May 15, 2023 | Sell | 5,675 | $232.1041 | $1.3M |
| Douglas Robert Andrew | May 15, 2023 | Sell | 1,500 | $232.85 | $350,000 |
| Sandercock Brett | May 10, 2023 | Sell | 12,574 | $233.1315 | $2.9M |
| Sandercock Brett | May 9, 2023 | Sell | 3,426 | $232.049 | $790,000 |
| FARRELL PETER C | May 3, 2023 | Sell | 12,600 | $237.1726 | $3M |
| PENDARVIS DAVID | May 3, 2023 | Sell | 1,500 | $237.64 | $360,000 |
| Ghoshal Kaushik | May 1, 2023 | Sell | 500 | $239.3 | $120,000 |
| Ghoshal Kaushik | Apr 24, 2023 | Sell | 2,000 | $230 | $460,000 |
| Douglas Robert Andrew | Apr 17, 2023 | Sell | 1,500 | $224.65 | $340,000 |
| Farrell Michael J. | Apr 17, 2023 | Sell | 5,675 | $224.2337 | $1.3M |
| PENDARVIS DAVID | Apr 3, 2023 | Sell | 1,500 | $218.23 | $330,000 |
| Ghoshal Kaushik | Apr 3, 2023 | Sell | 500 | $220 | $110,000 |
| Farrell Michael J. | Mar 15, 2023 | Sell | 5,675 | $206.9517 | $1.2M |
| Douglas Robert Andrew | Mar 15, 2023 | Sell | 1,500 | $206.14 | $310,000 |
| PENDARVIS DAVID | Mar 3, 2023 | Sell | 1,500 | $216.69 | $330,000 |
| Ghoshal Kaushik | Mar 3, 2023 | Sell | 1,000 | $220 | $220,000 |
| Sandercock Brett | Feb 17, 2023 | Sell | 10,000 | $215.2196 | $2.2M |
| Douglas Robert Andrew | Feb 15, 2023 | Sell | 1,500 | $213.5 | $320,000 |
| Farrell Michael J. | Feb 15, 2023 | Sell | 5,675 | $214.8271 | $1.2M |
| Sandercock Brett | Feb 13, 2023 | Sell | 4,000 | $215 | $860,000 |
| PENDARVIS DAVID | Feb 3, 2023 | Sell | 1,500 | $224.5 | $340,000 |
| Drexler Karen | Feb 2, 2023 | Sell | 594 | $226.58 | $130,000 |
| Douglas Robert Andrew | Jan 17, 2023 | Sell | 1,500 | $220.43 | $330,000 |
| Farrell Michael J. | Jan 17, 2023 | Sell | 5,675 | $224.3645 | $1.3M |
| PENDARVIS DAVID | Jan 3, 2023 | Sell | 1,500 | $210.07 | $320,000 |
| Farrell Michael J. | Dec 15, 2022 | Sell | 5,675 | $215.6348 | $1.2M |
| PENDARVIS DAVID | Dec 5, 2022 | Sell | 1,500 | $229.81 | $340,000 |
| Leong Justin | Nov 22, 2022 | Sell | 3,777 | $229.4995 | $870,000 |
| Douglas Robert Andrew | Nov 15, 2022 | Sell | 11,280 | $222.0691 | $2.5M |
| Farrell Michael J. | Nov 15, 2022 | Sell | 5,675 | $224.6409 | $1.3M |
| BLAISE LUCILE | Nov 15, 2022 | Sell | 169 | $225.18 | $38,000 |
| Farrell Michael J. | Nov 10, 2022 | Sell | 4,880 | $220.83 | $1.1M |
| Sandercock Brett | Nov 7, 2022 | Sell | 4,000 | $212.0169 | $850,000 |
What's the latest insider transaction for Resmed?
The most recent insider transaction for Resmed was conducted by Ghoshal Kaushik, who sold 4,260 shares on October 11, 2024 at a price of $238.48 per share.
Which insider has sold the most RMD stock over the last two years?
Farrell Michael J. has sold the most RMD stock in the last 2 years, with a total value of $35M.
What is the total value of insider transactions for Resmed (RMD) in the last 2 years?
The total value of insider transactions for Resmed in the last 2 years is negative, amounting to -$78M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Resmed's market confidence?
Over the last 2 years, insider transactions for Resmed have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
